GSC-enriched protein, BMI1, is required to prevent p53-mediated apoptosis, suggesting that GSCs preferentially avoid TMZ-induced apoptosis, conferring therapeutic resistance to GBM [31]. Here, TP53 is linked to glioblastoma.